Category: Editorial Message
The Connection Between Breast Cancer and Obesity
Christopher D. Still, DO, FACN, FACP, is the Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As you all are aware, October is breast cancer awareness month, so I thought it was […]
News and Notes from the September 2021 Issue of BT
by John M. Morton, MD, MPH, MHA, FACS, FASMBS, DABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, Welcome to the September 2021 issue of Bariatric Times. We […]
Weight Bias in a Weight Management Program?? You Bet!
by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, I know I have discussed this topic before, but after hearing an excellent lecture on weight bias […]
The Future of Bariatric Surgery? Three S’s
by John M. Morton, MD, MPH, MHA, FACS, FASMBS, DABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, I was recently giving a lecture and was relating that […]
What’s in your…Genes
by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As discussed on my June editorial message, semaglutide 2.4mg was FDA approved for the treatment of obesity, […]
News and Notes from the July 2021 Issue of BT
by John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, Welcome to the July 2021 issue of Bariatric Times. As […]
How to Evaluate Post-pandemic Weight Regain
by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, With the pandemic hopefully in our rearview mirror, we are left with most patients emerging with varying […]
Getting Back to Work
by John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, As we watch COVID-19 cases plummet and vaccinations surge, I […]
Semaglutide 2.4mg—One Giant STEP for Obesity Treatment??
by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, This is a very exciting time for clinicians treating obesity. Expected soon is the United States Food […]
News and Notes from the May 2021 Issue of BT
John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, Welcome to the May 2021 issue of Bariatric Times! As the […]
